Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy

Other OA: gold CC0 ⤵ 3 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated the inhibition of steroid sulfatase activity in endometriotic implants using STX64 (667Coumate), proposing it as a potential new therapy for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a common and debilitating condition of women in their reproductive age that is associated with pain and infertility. Current medical treatments are only partially effective and associated with wide-ranging side effects. New understanding of local estrogen production by endometriotic tissue and the availability of powerful suppressing drugs may herald a new era in the treatment of this condition.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Coumarins Endometriosis Enzyme Inhibitors Steryl-Sulfatase Steryl-Sulfatase Sulfonamides Sulfonic Acids Adult Adult Coumarins Coumarins Coumarins Disease Progression Disease Progression Endometriosis Endometriosis Enzyme Inhibitors Enzyme Inhibitors Estrogens Estrogens

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (11)

Cited by (3)

Source provenance

europepmc
last seen: 2026-10-12T06:17:10.165071+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:06:07.402396+00:00
License: CC0 · commercial use OK